AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05894239 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Taxane-based Chemotherapy
Description: During the induction therapy phase, the investigator's choice of taxane-based chemotherapy will be administered after Phesgo.
Study NCT04104477 — intervention group
Intervention type: OTHER
Intervention: Strength Tasks
Description: Participants will perform strength (pinch and grip) tests to evaluate fine and gross motor function.
Study NCT05894239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Optional Endocrine Therapy of Investigator's Choice
Description: Optional endocrine therapy (ET) is allowed at the discretion of the investigator, based on the standard of care. Allowed ETs are tamoxifen, or one of the specified third-generation aromatase inhibitor (AI \[anastrozole, letrozole, or exemestane\]), or fulvestrant. The investigator will determine and supply the appropriate luteinizing hormone-releasing hormone (LHRH) agonist locally approved for use in breast cancer. The LHRH agonist will be administered according to local prescribing information.
Study NCT05894239 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Optional Endocrine Therapy of Investigator's Choice
Description: Optional endocrine therapy (ET) is allowed at the discretion of the investigator, based on the standard of care. Allowed ETs are tamoxifen, or one of the specified third-generation aromatase inhibitor (AI \[anastrozole, letrozole, or exemestane\]), or fulvestrant. The investigator will determine and supply the appropriate luteinizing hormone-releasing hormone (LHRH) agonist locally approved for use in breast cancer. The LHRH agonist will be administered according to local prescribing information.
Study NCT04722679 — intervention group
Intervention type: DRUG
Intervention: Non-VKA Oral Anticoagulants (NOAC)
Description: Follow clinical practice.
Study NCT05575843 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Neurostatus-SMARTCARE
Description: The Neurostatus-EDSS is assessed by HCPs while the examination is video-recorded. HCPs underwent extended training. For details of the examination refer to the second section of the detailed description.
Study NCT05575843 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Neurostatus-EDSS
Description: The Neurostatus-EDSS is assessed by neurologists while the examination is video-recorded. Neurologists underwent standard training.
Study NCT04812015 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: transcutaneous auricular vagus nerve stimulation (taVNS) 15 minutes
Description: Sham 60 minutes and taVNS active stimulation for 15 minutes
Study NCT04812015 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: taVNS 30 minutes
Description: Sham 45 minutes and taVNS active stimulation for 30 minutes
Study NCT04812015 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: taVNS 45 minutes
Description: Sham 30 minutes and taVNS active stimulation for 45 minutes
Study NCT06255990 — intervention group
Intervention type: OTHER
Intervention: Standard of care
Description: Standard of care
Study NCT06403384 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vibration
Description: Local vibration was applied
Study NCT04812015 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: taVNS 60 minutes
Description: Sham 15 minutes and taVNS active stimulation for 60 minutes
Study NCT04812015 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: taVNS 75 minutes
Description: Sham 0 minutes and taVNS active stimulation for 75 minutes
Study NCT04812015 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: taVNS 0 minutes
Description: Sham taVNS 75 minutes
Study NCT05441579 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Economics (BE) recruitment strategies
Description: Behavioral economics (BE), a method of economic analysis that applies psychological insights into human behavior to explain economic decision-making, has broad applicability and its techniques offer a novel way that may be applied to try to help enhance study recruitment and enrollment.
Study NCT05441579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofeedback-based virtual reality (VR-BF)
Description: Phase 1 will focus on patients that would be enrolled into a biofeedback-based virtual reality (VR-BF) arm.
Study NCT05441579 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Biofeedback-based virtual reality (VR-BF)
Description: Phase 1 will focus on patients that would be enrolled into a biofeedback-based virtual reality (VR-BF) arm.
Study NCT05214144 — intervention group
Intervention type: OTHER
Intervention: PRO Instruments assessment questionnaire
Description: Patient Reported Outcome (PRO) questionnaire consisting of:~* PRO-CTCAE (approximately 11 questions plus free text)~* Patient-Reported Outcomes Measurement Information System (PROMIS) physical function short form (version 8c) (8 questions)~* PRO ECOG question (1 question)~* EORTC Quality of Life questionnaire (QLQ)-F17 questions (17 questions)~* Functional Assessment of Cancer Therapy-General version, rated on a 5-point Likert scale, (FACT-GP5) (single item global side effect bother question) (1 question)~* The Patient Global Impression (PGI)-C and PGI-S items (anchors for physical function) (2 questions)
Study NCT05214144 — intervention group
Intervention type: OTHER
Intervention: Baseline Survey Clinician- reported (ClinRO) ECOG
Description: Baseline Survey completed prior to initiation of chemotherapy
Study NCT05214144 — intervention group
Intervention type: DEVICE
Intervention: Fitbit
Description: wearable device
Study NCT05214144 — intervention group
Intervention type: OTHER
Intervention: Hugo Health (Hugo)
Description: an electronic platform that aggregates real world EHR data with patient's wearable and PRO data
Study NCT05214144 — intervention group
Intervention type: OTHER
Intervention: 6 Minute Walk Test (6MWT)
Description: A comprehensive performance measure of exercise capacity, encompassing components of mobility, endurance, and functional capacity measure (PerfO)
Study NCT04534985 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dietary
Description: Dietary intake behavioral intervention via time restricted feeding and normal healthy eating recommendations vs. normal healthy eating recommendations without restricted
Study NCT04534985 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary
Description: Dietary intake behavioral intervention via time restricted feeding and normal healthy eating recommendations vs. normal healthy eating recommendations without restricted
Study NCT05004480 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treadmill
Description: Electronic treadmill, Hammer T-2000 Treadmill, 2,5 HP - 140 Kilograms
Study NCT04895787 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gait + aerobic exercise
Description: Following skill-based gait training, the participants in the AEX group will engage in 20 minutes of moderate to high intensity aerobic exercise on a recumbent bicycle. The participants will first perform a brief warm-up, followed by 20 minutes of moderate to high intensity aerobic exercise pedaling at 60-80 rpm with a target heart rate range between 60-70% of heart rate reserve (HRR). Given the potential of having autonomic dysfunction in this population, it has been suggested that a RPE scale between 14-17 is appropriate.
Study NCT04895787 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gait + resistance exercises
Description: Following skill-based gait training, the participants in the REX group will engage in resistance training, which will target major muscle groups important for daily activities. The resistance training will be provided with free weights or therabands at an intensity of 8-12 repetition maximum (RM). Each muscle group should be trained with 8-12 repetitions ranging from 1 to 3 sets with resting intervals provided between each set. The target RPE scale will be set between 14-17, and the training load will be progressively increased as the participants improved.
Study NCT04895787 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Gait + conventional physical therapy
Description: Following skill-based gait training, the participants in the CPT group will receive conventional physical therapy, which may include stretching exercise, balance training, or practice over-ground walking based on the participant's need.
Study NCT05002140 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XRD-0394
Description: Single ascending dose
Study NCT05002140 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Palliative radiotherapy
Description: 4 Gy × 5 daily fractions
Study NCT05441579 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manage My Pain
Description: Commercially available and free app to track, analyze and monitor pain.
Study NCT05441579 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Manage My Pain
Description: Commercially available and free app to track, analyze and monitor pain.
Study NCT05137626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AT-527 + digoxin
Description: * Day 1: A single dose of digoxin will be administered.~* Day 15: A single dose of AT-527 and digoxin will be co-administered.
Study NCT05137626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AT-527 + digoxin
Description: * Day 1: A single dose of digoxin will be administered.~* Day 15: A single staggered dose of AT-527 and digoxin will be administered (2 hours later).
Study NCT06347159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDG-7500
Description: Liquid suspension formulation of EDG-7500
Study NCT06347159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDG-7500
Description: Solid oral formulation of EDG-7500
Study NCT06481176 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 12-Week RLS Exercise Program
Description: Participants will complete 12 weeks of an evidence-based exercise program that has been used for people with RLS, designed for people with RLS, and was informed by exercise guidelines outlined by the American College of Sports Medicine (ACSM) and the American Heart Association, and Center for Disease Control.~The program includes three sessions per week for 12 weeks including:~* cardiovascular exercise (e.g., walking/jogging, bicycling) for 30 minutes/day on at least 3 days/week at a moderate-to-vigorous intensity~* strength training on 2 non-consecutive days/week targeting major muscle groups for approximately 30 minutes~* Stretching all major muscle groups on three or more days per week
Study NCT04711135 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lutetium [177Lu] oxodotreotide/dotatate
Description: Radiopharmaceutical solution for infusion (7.4 GBq of Lutathera per 30 ml vial)
Study NCT04945642 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: High-Dose Rate Brachytherapy
Description: Undergo HDR-BT
Study NCT04945642 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy
Description: Undergo SBRT
Study NCT04999774 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Different diagnostic tests
Description: Each SAC will be tested with all tests
Study NCT04699253 — intervention group
Intervention type: DEVICE
Intervention: SanaCoach Heart failure
Description: Patients will be using the SanaCoach heart failure for at least 6 months during the study period. SanaCoach heart failure is a web application that will be guiding the patient through a regular, systematic assessment of patient's health and wellbeing as well as regular education sessions. The assessment frequency ranges from daily to monthly, based on the settings provided by the health care provider. Furthermore, it provides a repository for patient's care plan to give insight into the course and treatment of the disorder and offers the possibility to contact the health care provider through the web application.
Study NCT04802005 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Interval Training
Description: The aerobic interval training group
Study NCT05656274 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JS1-1-01
Description: Oral tables
Study NCT05656274 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tables
Study NCT05454891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Extended bolus of insulin then standard bolus of insulin
Description: For a standardized HFHP breakfast, participants will receive an extended meal bolus of insulin on the first morning and a standard meal bolus of insulin on the second morning of the study.
Study NCT05454891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard bolus of insulin then extended bolus of insulin
Description: For a standardized HFHP breakfast, participants will receive a standard bolus of insulin on the first morning and an extended bolus of insulin on the second morning of the study.
Study NCT05198505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB2868 Injection
Description: TQB2868 protein is a bi-functional fusion protein targeting PD-1 and TGF-β
Study NCT05815329 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cognitive training
Description: After the multidimensional evaluation at T0, the participants will be randomly allocated into an experimental group and a wait list control group. Specifically, cognitive training will be offered to half of the outpatients included in this research by means of technological devices (Neurotablet). A neuropsychologist will supervise the cognitive training offline (about 30 minutes per 5 days, 8 weeks) and through a face-to-face 1 hour-session each week per each outpatient.
Study NCT05828264 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Quantum touch
Description: this group by the nurse who is included in the study and who has a practice certificate before vascular access is established. In this process, the treatment process of the patient will continue and will not create an obstacle. While the child is in a comfortable position (lying or sitting position) during the application, the child's back/shoulder/head will be touched by the practitioner and guantum touch energy will be applied. Then, vascular access will be performed by the nurse included in the study. The child will be asked to rate the level of pain during the procedure with 'FPS-R', the level of fear with 'CDS', and the level of anxiety with 'ÇAS-D'.
Study NCT04841629 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PreBioGyn Gel
Description: Cellulose-based prebiotic gel developed to optimize vaginal health and reduce the risk of cervical cancer in women.
Study NCT04841629 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Trimosan Gel
Description: Carbomer-based gel
Study NCT04841629 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: RepHresh Gel
Description: Carbomer-based gel
Study NCT05725798 — intervention group
Intervention type: DRUG
Intervention: Sitagliptin
Description: Group 1 who regularly takes Sitagliptin due to diabetes mellitus type 2 continues the treatment perioperatively. Group 2 and group 3 do not take Sitagliptin.
Study NCT05603624 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cervical examination to assess labor
Description: Patients were randomized to receive cervical examinations to assess progression in labor with either sterile or clean gloves.
Study NCT05603624 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cervical examination to assess labor
Description: Patients were randomized to receive cervical examinations to assess progression in labor with either sterile or clean gloves.
Study NCT04718987 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Low dose rate (LDR) brachytherapy
Description: Low dose rate (LDR) brachytherapy is a type of radiation treatment where doctor places the radioactive implants (seeds) inside patient's prostate gland and these seeds emits low dose radiation over a certain period of time. During low-dose-rate brachytherapy, a continuous low dose of radiation is released over time -from several hours to several days.
Study NCT04895787 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Gait + rest
Description: Following skill-based gait training, the participants will sit and rest on a chair.
Study NCT06039891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nimotuzumab、Tislelizumab
Description: Subjects will receive Nimotuzumab 400 mg/time, intravenous injection, qw; Tislelizumab 200 mg/time, q3w until disease progression, intolerable toxicity, or 24 months of medication
Study NCT06192446 — intervention group
Intervention type: DRUG
Intervention: Survey using a questionnaire.
Description: An observational study conducted in a cross-sectional manner using a questionnaire.
Study NCT04877548 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fermented orange flour
Description: Volunteers will have to consume a standardized breakfast including fermented orange flour and presenting 50g of available carbohydrates
Study NCT04877548 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fermented grape flour
Description: Volunteers will have to consume a standardized breakfast including fermented grape flour and presenting 50g of available carbohydrates
Study NCT04877548 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Volunteers will have to consume a standardized breakfast without fermented flour but also presenting 50g of available carbohydrates
Study NCT06257979 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: This study is with minimal risk and minimal constraints due to the addition of questionnaires
Description: In this study, the specific procedures compared to routine care are :~* Considering the addition of questionnaires, this study will be prospective. Due to the use of bacteriological samples, it is considered as a minimal-risk research.~* The research procedure involves a bacteriological analysis of operative elements (sutures placed during the first intervention, the product of tendon debridement, and the subacromial bursa (cleaning product)) used during the re-intervention. These usually discarded operative samples are collected for bacteriological analysis.~* Antibiotic treatment cannot be prescribed immediately after the surgery and during the first month following this re-intervention (time for biofilm formation). As per the protocol, even a positive sample should not lead to the initiation of systematic antibiotic therapy. In the case of identification of a pathogenic microorganism, antibiotic therapy will be prescribed, leading to discontinuation of the study.
Study NCT06463262 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ctDNA
Description: the effects of neoadjuvant RT, in the form of either proton therapy or SBRT, on the ctDNA
Study NCT05303441 — intervention group
Intervention type: PROCEDURE
Intervention: percutaneous coronary intervention
Description: conventional coronary angiography
Study NCT06066671 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: GCO (Experimental copaiba oil resin gel)
Description: Prior to bleaching treatment with 35% hydrogen peroxide, the dental elements of the GCO will receive the application of the experimental desensitizing gel on the buccal surfaces of the central incisors, lateral incisors, canines and upper and lower premolars, with a rubber cup in an active way, for 10 minutes.
Study NCT06066671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GCO (Experimental copaiba oil resin gel)
Description: Prior to bleaching treatment with 35% hydrogen peroxide, the dental elements of the GCO will receive the application of the experimental desensitizing gel on the buccal surfaces of the central incisors, lateral incisors, canines and upper and lower premolars, with a rubber cup in an active way, for 10 minutes.
Study NCT06066671 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: GCO (Experimental copaiba oil resin gel)
Description: Prior to bleaching treatment with 35% hydrogen peroxide, the dental elements of the GCO will receive the application of the experimental desensitizing gel on the buccal surfaces of the central incisors, lateral incisors, canines and upper and lower premolars, with a rubber cup in an active way, for 10 minutes.
Study NCT05842720 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: un-sedated colonoscopies
Description: un-sedated colonoscopies in high risk patients with ASA>=3
Study NCT05975112 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Coagulation tests (TEG, Levels of F1, F2, hs-D-dimer, Plasminogen, PAI 1+2), SpHb before discharge
Description: Coagulation tests named earlier as well as SpHb
Study NCT05958381 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: Transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. Stimulation will consist of 1 milliamp stimulation, with anodal stimulation delivered at electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, then remain at 1 milliamp of stimulation over 20 minutes, and finally ramping down at to 0 milliamps over 60 seconds.
Study NCT05958381 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham transcranial direct current stimulation
Description: Sham transcranial direct current stimulation will be delivered via a Neuroelectrics Starstim tES. The sham setup will consist of anodal electrode Fz (International 10/10 System for electroencephalography electrode placement) and electrodes F7, FP1, FP2, and F8 as returns. All electrodes are 1 cm diameter Ag/AgCl electrodes and make contact with the scalp via connective gel. Stimulation will linearly ramp up from 0 milliamps to 1 milliamp over 60 seconds, ramp down to 0 milliamps over 60 seconds and then be left off for 20 minutes.